Next, mice with CLL pretreatment or lacking most LNs owing to in utero LTβR-Fc treatment (LN-less) were injected with 0.1 μg Dex-FITC, an amount with low blood leakage in the control. Here, LTBR is linked to B-cell chronic lymphocytic leukemia.